CDH Venture

CDH Venture Capital is the venture and growth-stage investment arm of CDH Investments, one of China's largest and most established alternative asset management firms. The firm maintains a significant focus on the healthcare and life sciences sectors, investing across biotechnology, pharmaceuticals, medical devices, and healthcare services. CDH Venture is known for its strategic role in scaling innovative Chinese healthcare companies and facilitating cross-border acquisitions, such as the landmark acquisition of Sirtex Medical. Its portfolio includes prominent industry leaders like Innovent Biologics and Burning Rock Biotech, reflecting its deep expertise in the Asian healthcare market.